Reviva Pharmaceuticals (RVPHW) Short Interest Ratio & Short Volume $0.05 0.00 (-4.10%) Closing price 04/17/2025 03:45 PM EasternExtended Trading$0.05 -0.01 (-10.70%) As of 04/17/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Reviva Pharmaceuticals Short Interest DataReviva Pharmaceuticals (RVPHW) has a short interest of 15,900 shares. This marks a 106.49% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 31,891 shares to cover all short positions.Current Short Interest15,900 sharesPrevious Short Interest7,700 sharesChange Vs. Previous Month+106.49%Dollar Volume Sold Short$872.91Short Interest Ratio0.3 Days to CoverLast Record DateMarch 31, 2025Today's Trading Volume36,776 sharesAverage Trading Volume31,891 sharesToday's Volume Vs. Average115% Short Selling Reviva Pharmaceuticals? Sign up to receive the latest short interest report for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRVPHW Short Interest Over TimeRVPHW Days to Cover Over TimeRVPHW Percentage of Float Shorted Over Time Reviva Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202515,900 shares $872.91 +106.5%N/A0.3 $0.05 3/15/20257,700 shares $465.08 +234.8%N/A0.2 $0.06 2/28/20252,300 shares $299.00 -36.1%N/A0.1 $0.13 2/15/20253,600 shares $468.00 -45.5%N/A0.1 $0.13 1/31/20256,600 shares $1,273.80 -55.7%N/A0.2 $0.19 1/15/202514,900 shares $3,047.05 +325.7%N/A0.4 $0.20 12/31/20243,500 shares $575.40 -73.5%N/A0.1 $0.16 12/15/202413,200 shares $4,092.00 -24.6%N/A0.5 $0.31 11/30/202417,500 shares $3,762.50 +21.5%N/A0.8 $0.22 11/15/202414,400 shares $2,737.44 +585.7%N/A1 $0.19 Get the Latest News and Ratings for RVPHW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/31/20242,100 shares $210.00 +40.0%N/A0.1 $0.10 10/15/20241,500 shares $149.55 -42.3%N/A0.1 $0.10 9/30/20242,600 shares $351.00 -21.2%N/A0.1 $0.14 9/15/20243,300 shares $346.50 -66.7%N/A0.2 $0.11 8/31/20249,900 shares $1,188.00 -20.8%N/A0.6 $0.12 8/15/202412,500 shares $1,046.88 -12.0%N/A0.8 $0.08 7/31/202414,200 shares $1,988.00 -49.3%N/A1 $0.14 7/15/202428,000 shares $6,188.00 +34.6%N/A2 $0.22 6/30/202420,800 shares $5,616.00 -1.4%N/A1.5 $0.27 6/15/202421,100 shares $6,541.00 -8.3%N/A1.5 $0.31 5/31/202423,000 shares $6,854.00 +67.9%N/A1.3 $0.30 5/15/202413,700 shares $4,110.00 +8.7%N/A0.7 $0.30 4/30/202412,600 shares $5,670.00 -3.8%N/A0.7 $0.45 4/15/202413,100 shares $6,550.00 -16.0%N/A0.8 $0.50 3/31/202415,600 shares $9,837.36 -7.1%N/A0.9 $0.63 3/15/202416,800 shares $12,416.88 -14.7%N/A0.9 $0.74 2/29/202419,700 shares $16,197.34 -33.9%N/A1.2 $0.82 2/15/202429,800 shares $23,244.00 -28.7%N/A2 $0.78 1/31/202441,800 shares $41,800.00 +36.2%N/A2.2 $1.00 1/15/202430,700 shares $34,691.00 +16.3%N/A1.2 $1.13 12/31/202326,400 shares $37,752.00 +67.1%N/A1 $1.43 12/15/202315,800 shares $12,124.92 -19.4%N/A0.6 $0.77 11/30/202319,600 shares $15,680.00 -54.1%N/A0.7 $0.80 11/15/202342,700 shares $58,072.00 -35.4%N/A1.5 $1.36 10/31/202366,100 shares $79,320.00 -1.1%N/A2.5 $1.20 10/15/202366,800 shares $106,212.00 +0.2%N/A2.6 $1.59 9/30/202366,700 shares $102,718.00 +18.7%N/A2.5 $1.54 9/15/202356,200 shares $97,490.14 +34.5%N/A2.1 $1.73 8/31/202341,800 shares $43,467.82 -3.9%N/A1.5 $1.04 8/15/202343,500 shares $45,235.65 -22.5%N/A1.4 $1.04🥾⛏️👷♂️ What I Learned From Numerous Mine Visits... (Ad)Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining stocks like most gold analyst CFAs, I decided to visit every significant gold mine I could. 10+ site visits later, I've confirmed my theory... That the most profitable mines share three specific characteristics. When you find all three together, the returns can be staggering.Go here to learn about my Top Four picks for the coming bull mania. 7/31/202356,100 shares $71,808.00 -2.9%N/A1.7 $1.28 7/15/202357,800 shares $84,388.00 -11.2%N/A1.4 $1.46 6/30/202365,100 shares $115,292.10 -0.6%N/A1.5 $1.77 6/15/202365,500 shares $117,893.45 -5.4%N/A1.6 $1.80 5/31/202369,200 shares $119,024.00 -18.1%N/A1.6 $1.72 5/15/202384,500 shares $200,265.00 +11.9%N/A2.3 $2.37 4/30/202375,500 shares $154,020.00 +57.3%N/A2.3 $2.04 4/15/202348,000 shares $57,580.80 +1.7%N/A1.9 $1.20 3/31/202347,200 shares $47,200.00 No ChangeN/A2.5 $1.00 3/15/202347,200 shares $46,251.28 -6.0%N/A2.5 $0.98 2/28/202350,200 shares $52,710.00 -1.8%N/A2.3 $1.05 2/15/202351,100 shares $50,078.00 +10.1%N/A1.9 $0.98 1/31/202346,400 shares $47,792.00 -11.5%N/A1 $1.03 1/15/202352,400 shares $48,732.00 -0.4%N/A0.7 $0.93 12/30/202252,600 shares $52,074.00 +3.5%N/A0.5 $0.99 12/15/202250,800 shares $54,356.00 -31.9%N/A0.5 $1.07 11/30/202274,600 shares $84,298.00 +10.2%N/A0.6 $1.13 11/15/202267,700 shares $62,290.77 -3.7%N/A0.5 $0.92 10/31/202270,300 shares $42,180.00 +52.2%N/A0.6 $0.60 10/15/202246,200 shares $27,572.11 +103.5%N/A0.6 $0.60 9/30/202222,700 shares $4,335.70 -9.2%N/A0.5 $0.19 9/15/202225,000 shares $9,149.98 +5.0%N/A0.6 $0.37 8/31/202223,800 shares $6,904.40 +65.3%N/A0.7 $0.29 8/15/202214,400 shares $2,302.56 -4.6%N/A0.6 $0.16 7/31/202215,100 shares $2,263.49 -95.9%N/A0.7 $0.15 7/15/2022364,900 shares $69,185.04 +2,332.7%N/A19.3 $0.19 6/30/202215,000 shares $2,701.50 +10.3%N/A0.8 $0.18 6/15/202213,600 shares $2,313.37 -25.7%N/A0.7 $0.17 5/31/202218,300 shares $3,841.17 -14.1%N/A1 $0.21 5/15/202221,300 shares $4,698.78 +10.4%N/A1.5 $0.22 4/30/202219,300 shares $0.00 +7.2%N/A1.3 $0.00 RVPHW Short Interest - Frequently Asked Questions What is Reviva Pharmaceuticals' current short interest? Short interest is the volume of Reviva Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 15,900 shares of RVPHW short. Learn More on Reviva Pharmaceuticals' current short interest. Which institutional investors are shorting Reviva Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Reviva Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Reviva Pharmaceuticals' short interest increasing or decreasing? Reviva Pharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 15,900 shares, an increase of 106.5% from the previous total of 7,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Reviva Pharmaceuticals stock? Short selling RVPHW is an investing strategy that aims to generate trading profit from Reviva Pharmaceuticals as its price is falling. RVPHW shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Reviva Pharmaceuticals? A short squeeze for Reviva Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RVPHW, which in turn drives the price of the stock up even further. How often is Reviva Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RVPHW, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies ALVOW Short Squeeze BCTXW Short Squeeze CLNNW Short Squeeze ENGNW Short Squeeze FBIOP Short Squeeze IMTXW Short Squeeze JSPRW Short Squeeze LEXXW Short Squeeze LIXTW Short Squeeze NLSPW Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RVPHW) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVPHW Stock Free RVPHW Stock Alerts